Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting

Bibliographic Data

ID19442322
AuthorsBrenden Joseph (St. Paul's Hospital), Thomas Kerr (0000-0002-0870-7153, University of British Columbia), Cathy M Puskas (0000-0002-3619-5060, St. Paul's Hospital), Julio Montaner (0000-0002-6201-9829, St. Paul's Hospital), Evan Wood (0000-0001-9412-6699, St. Paul's Hospital), M-J Milloy (0000-0003-2178-1355), M‐j Milloy (0000-0003-3821-6221, St. Paul's Hospital, corresponding author)
Year2015
Volume27
Issue9
Pages1128-1136
Publication date2015-09-02
Open AccessNo
TypeARTICLE
VenueAIDS Care (JOURNAL)
Journal identifiersISSN: 0954-0121 • E-ISSN: 1360-0451
PublisherInforma UK Limited (PUBLISHER • GB)
DOI10.1080/09540121.2015.1032205
PMID25915438
OpenAlexW2026207295
LanguageEN
Citations received12
References cited48

HIV-positive people who use illicit drugs typically achieve lower levels of adherence to antiretroviral therapy and experience higher rates of sub-optimal HIV/AIDS treatment outcomes. Given the dearth of longitudinal research into ART adherence dynamics, we sought to identify factors associated with transitioning into and out of optimal adherence to ART in a longitudinal study of HIV-infected people who use illicit drugs (PWUD) in a setting of universal no-cost HIV/AIDS treatment. Using data from a prospective cohort of community-recruited HIV-positive illicit drug users confidentially linked to comprehensive HIV/AIDS treatment records, we estimated longitudinal factors associated with losing or gaining ≥95% adherence in the previous six months using two generalized linear mixed-effects models. Among 703 HIV-infected ART-exposed PWUD, becoming non-adherent was associated with periods of homelessness (adjusted odds ratio [AOR] = 2.52, 95% confidence interval [95% CI]: 1.56-4.07), active injection drug use (AOR = 1.25, 95% CI: 1.01-1.56) and incarceration (AOR = 1.54, 95% CI: 1.10-2.17). Periods of sex work (AOR = 0.51, 95% CI: 0.34-0.75) and injection drug use (AOR = 0.62, 95% CI: 0.50-0.77) were barriers to becoming optimally adherent. Methadone maintenance therapy was associated with becoming optimally adherent (AOR = 1.87, 95% CI: 1.50-2.33) and was protective against becoming non-adherent (AOR = 0.52, 95% CI: 0.41-0.65). In conclusion, we identified several behavioural, social and structural factors that shape adherence patterns among PWUD. Our findings highlight the need to consider these contextual factors in interventions that support the effective delivery of ART to this population

Antiretroviral therapy · Cohort · Cohort study · Confidence interval · Drug · Drug injection · Generalized estimating equation · Injection drug use · Longitudinal study · Methadone · Methadone maintenance · Odds ratio · Prospective cohort study · Psychiatry · Viral load · Demography · HIV, Drug Use, Sexual Risk · HIV/AIDS drug development and treatment · HIV/AIDS Research and Interventions · Medicine · Immunology · Internal Medicine

  • Antiretroviral Therapy Interruption Among HIV Postive People Who Use Drugs in a Setting with a Community-Wide HIV Treatment-as-Prevention Initiative

    Open Access•Robert Mcneil, Thomas Kerr et al.•AIDS and Behavior•2016

  • It’s all about connection

    Open Access•Clara Tam, Tim Wesseling et al.•BMC Public Health•2023

  • Prevalence and Correlates of Reporting Difficulty Taking Antiretroviral Treatment Among HIV-Positive Illicit Drug Users in Vancouver, Canada

    Open Access•Bianca Yeung, NA Mohd Salleh et al.•AIDS and Behavior•2018

  • Effectiveness of a Viral Load Suppression Intervention for Highly Vulnerable People Living with HIV

    Open Access•Toorjo Ghose, Virginia Shubert et al.•AIDS and Behavior•2019

  • The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States

    Open Access•Yuehan Zhang, Tracey E Wilson et al.•AIDS and Behavior•2017

  • Criminal Justice System Involvement as a Risk Factor for Detectable Plasma HIV Viral Load in People Who Use Illicit Drugs

    Open Access•Sarah Ickowicz, NA Mohd Salleh et al.•AIDS and Behavior•2019

  • Severity and Number of Substances Used are Independently Associated with Antiretroviral Therapy Adherence Over Time among People with HIV in the Current Treatment Era

    Open Access•Jimmy Ma, Joseph Delaney et al.•AIDS and Behavior•2024

  • Social and Structural Factors Associated with Sustained Viral Suppression Among Heterosexual Black Men with Diagnosed HIV in the United States, 2015–2017

    Open Access•Donna Hubbard Mccree, Linda Beer et al.•AIDS and Behavior•2020

  • Identifying, linking, and treating people who inject drugs and were recently infected with HIV in the context of a network-based intervention

    Mina Psichogiou, Mina Psichοgiou et al.•AIDS Care•2019

  • HIV And HCV infection among opiate-dependent patients and methadone doses

    Carlos Roncero, Daniel Fuster et al.•AIDS Care•2017

  • Adherence to antiretroviral therapy among HIV positive men who inject drugs in Pakistan

    Open Access•Jenny Iversen, Salman ul Hasan Qureshi et al.•International Journal of Drug…•2021

  • Time-space constraints to HIV treatment engagement among women who use heroin in Dar es Salaam, Tanzania

    Open Access•Haneefa T Saleem, Samuel Likindikoki et al.•Social Science & Medicine•2021

  • Sex-work harm reduction

    Open Access•Michael L Rekart•The Lancet•2005

  • Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women

    Jared M Baeten, Deborah Donnell et al.•New England Journal of Medicine•2012

  • Accessing Antiretroviral Therapy Following Release From Prison

    Jacques Baillargeon•JAMA•2009

  • Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

    Frank Joseph Palella, Kathleen M Delaney et al.•New England Journal of Medicine•1998

  • The health of prisoners

    Open Access•Seena Fazel, Jacques Baillargeon•The Lancet•2011

  • Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1

    Thomas C Quinn, Maria J Wawer et al.•New England Journal of Medicine•2000

  • Barriers to Use of Free Antiretroviral Therapy in Injection Drug Users

    Steffanie A Strathdee•JAMA•1998

  • Sexual transmission of HIV-1 among injection drug users in San Francisco, USA

    Open Access•Alex H Kral, Ricky N Bluthenthal et al.•The Lancet•2001

  • Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population

    David R Bangsberg, FREDERICK HECHT et al.•AIDS•2000

  • Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users

    Open Access•Mônica Malta, Steffanie A Strathdee et al.•Addiction•2008

  • Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic

    Gregory M Lucas, Kelly A Gebo et al.•AIDS•2002

  • Treatment and care for injecting drug users with HIV infection

    Open Access•Daniel Wolfe, Patrizia Carrieri et al.•The Lancet•2010

  • Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic

    Mark Tyndall, Mark W Tyndall et al.•AIDS•2003

  • Heterosexual HIV-1 transmission after initiation of antiretroviral therapy

    Open Access•Deborah Donnell, Jared M Baeten et al.•The Lancet•2010

  • Needle exchange is not enough

    Steffanie A Strathdee, 晴義 山田 et al.•AIDS•1997

  • Adherence to Antiretroviral Therapy Among HIV-Infected Drug Users

    Open Access•Mônica Malta, Monica M F Magnanini et al.•AIDS and Behavior•2010

  • Barriers to Health and Social Services for Street-Based Sex Workers

    Steven P Kurtz, Hilary L Surratt et al.•Journal of Health Care for the…•2005

  • The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users

    Will Small, Evan Wood et al.•AIDS Care•2009

  • Surviving the sex trade

    Patricia M Spittal, Julie Bruneau et al.•AIDS Care•2003

  • Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting

    Seonaid Nolan, M-J Milloy et al.•AIDS Care•2011

  • Adherence to HIV Treatment and Care Among Previously Homeless Jail Detainees

    Open Access•Nadine E Chen, Jaimie P Meyer et al.•AIDS and Behavior•2011

  • Another Decade of Social Scientific Work on Sex Work

    Ine Vanwesenbeeck•Annual Review of Sex Research•2001

  • Social and structural determinants of Haart access and adherence among injection drug users

    Open Access•Andrea Krüsi, Evan Wood et al.•International Journal of Drug…•2010

  • Homelessness and Adherence to Antiretroviral Therapy among a Cohort of HIV-Infected Injection Drug Users

    Open Access•Anita Palepu, M‐j Milloy et al.•Journal of Urban Health•2011

  • Health Status, Health Care Use, Medication Use, and Medication Adherence Among Homeless and Housed People Living With HIV/Aids

    Daniel P Kidder, Richard J Wolitski et al.•American Journal of Public Health•2007

Citations per year1.2
Citation span2016 - 2024 (9)
Highly citedNo

Tools

Open DOISci-HubOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae